XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Jun. 30, 2023
Mar. 31, 2023
Cash flows from operating activities:        
Net income $ 40,532     $ 16,485
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization 42,835     40,181
Long-lived and other asset impairment 2,568     2,569
Non-cash restructuring charges       927
Unrealized change in fair value of investment in unconsolidated affiliate       254
Inventory write-downs 199     216
Amortization of operating lease right-of-use assets 947     823
Amortization of deferred financing costs 1,193     1,288
Amortization of debt premium (501)     (501)
Amortization of capitalized implementation costs 738     597
Stock-based compensation expense 3,964     3,327
Benefit from credit losses (75)     (340)
Gain on sale of assets, net (2,381)     (3,605)
Deferred income tax provision 12,460     5,881
Amortization of contract costs 5,768     5,090
Deferred revenue recognized in earnings (2,859)     (4,476)
Changes in operating assets and liabilities:        
Accounts receivable, net 19,819     7,632
Inventory 1,246     (4,131)
Other assets (1,785)     609
Contract costs (3,996)     (6,352)
Accounts payable and other liabilities 13,958     18,219
Deferred revenue 3,070     3,179
Other 2     (16)
Net cash provided by operating activities 137,702     87,856
Cash flows from investing activities:        
Capital expenditures (99,755)     (84,392)
Proceeds from sale of property, equipment and other assets 13,844     28,726
Proceeds from insurance and other settlements 45      
Investments in unconsolidated entities (57)     (2,000)
Net cash used in investing activities (85,923)     (57,666)
Cash flows from financing activities:        
Borrowings of long-term debt 244,525     158,850
Repayments of long-term debt (263,050)     (160,100)
Dividends paid to stockholders (26,000) $ (24,190) $ (23,504) (23,852)
Repurchases of common stock (1,230)      
Taxes paid related to net share settlement of equity awards (6,451)     (3,773)
Proceeds from stock issued under ESPP 244     170
Net cash used in financing activities (51,962)     (28,705)
Net increase (decrease) in cash and cash equivalents (183)     1,485
Cash and cash equivalents, beginning of period 1,338   $ 3,051 1,566
Cash and cash equivalents, end of period $ 1,155 $ 1,338   $ 3,051